- US 10-year Treasury yields hesitate to extend recent pullback, S&P 500 Futures stay sluggish despite upbeat Wall Street closing.
- Doubts over availability, effectiveness of vaccines/pills join China lockdown to weigh on risk appetite, stimulus hopes prevail.
- US Durable Goods Orders, PCE Inflation for November will be crucial for near-term direction.
- Omicron updates, US BBB news are important as well.
Following two consecutive days of risk-on, market sentiment dwindles during early Thursday.
While portraying the mood, the US 10-year Treasury yields seesaw around 1.457% after declining for the first time in three days on Wednesday whereas the S&P 500 Futures struggle to copy the Wall Street’s gains, up 0.05% around 4,687 by the press time.
It’s worth noting that fresh challenges to the previously positive risk catalysts and cautious mood ahead of the key US data seem to test the optimists amid a light calendar.
Among the negatives, China’s biggest-ever lockdown, of around 13 million residents in Xi’an as stated by the Wall Street Journal (WSJ) gains major attention. On the same line are the White House fears over the availability of Pfizer’s pill to battle the Omicron that recently got the US Food and Drug Administration (FDA) approval. Additionally, the Financial Times (FT) news stating, “France on Wednesday canceled its order of Merck’s drug after data showed it resulted in a reduction of only 30% in the risk of hospitalization and death, significantly lower than earlier expectations,” also challenge the previously upbeat market mood.
It’s worth observing, however, that the White House optimism over US President Joe Biden's Build Back Better (BBB) stimulus plan is likely battling the bears. Additionally, Japan’s positive GDP revision and push for a record budget joins US Military’s progress over having a single cure for all covid and variant, not to forget studies showing Omicron has lesser scope hospitalization, to keep the bulls hopeful.
Moving on, markets are likely to remain divided as traders approach Christmas Eve amid light volume. However, the US PCE inflation and Durable Goods Orders for November can entertain the momentum traders. Also important are the aforementioned risk catalysts like Omicron news and US stimulus updates.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.